ADNEXUS THERAPEUTICS, created in 2006 (United States), from 496 sister brands and 17477 competing brands. ADNEXUS THERAPEUTICS is owned by BRISTOL-MYERS SQUIBB COMPANY, listed on the stock exchange of New York ADNEXUS THERAPEUTICS belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY
(ADNEXUS THERAPEUTICS)
over 5 years*
USD 51.82